This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 29, 2026
We added search aliases that the cited FDA substance-identity record maps to this active ingredient. The profile's status did not change. 3
What this version reported
The cited DailyMed label identifies Tirzepatide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.↗
Organizations named in cited records:
- U.S. National Library of Medicine↗
Sources for this version
- 1ZEPBOUND (tirzepatide) injection · SPL version 38 · published 2026-05-06 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 2FDA approves tirzepatide for chronic weight management ↗
U.S. Food and Drug Administration · Official source · Source checked July 22, 2026
- 3Tirzepatide substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked July 29, 2026